Itoh, Takumi http://orcid.org/0000-0002-6535-1042
Hatano, Ryo
Horimoto, Yoshiya http://orcid.org/0000-0001-8935-0768
Yamada, Taketo
Song, Dan
Otsuka, Haruna
Shirakawa, Yuki
Mastuoka, Shuji
Iwao, Noriaki
Aune, Thomas M.
Dang, Nam H.
Kaneko, Yutaro
Okumura, Ko
Morimoto, Chikao
Ohnuma, Kei http://orcid.org/0000-0002-8126-3907
Article History
Received: 9 January 2021
Revised: 1 May 2021
Accepted: 3 May 2021
First Online: 21 May 2021
Ethics approval
: Animal experiments were conducted following protocols approved by the Animal Care and Use Committees at Juntendo University (300070). For clinical samples, human study protocols were approved by the Ethics Committees at Juntendo University Hospital (no: 17-252) and all specimens were collected after obtaining informed consent from the patients. All experiments were performed in accordance with relevant guidelines and regulations.
: T.I., R.H, C.M., and K.O. are the patent holders of anti-IL26 mAbs. The remaining authors declare no competing interests.